This whitepaper outlines a practical framework for designing scientifically justified, regulatory-ready IND packages that ...

The first proof-of-concept study showed that the gene therapy reduced the production of cerebrospinal fluid in the brains of ...

Discover how researchers are looking beyond individual neurons to understand how genetic variations shape activity across ...

The field of drug discovery is undergoing a profound transformation. Traditional small-molecule and biologic therapeutics — long the backbone of modern medicine — are now joined by a new generation of ...

Welcome to the Weekly Rundown where the DDN editors cover this week’s top biotech and pharma news.

Explore how dual binding assays reveal interactions between bispecific antibodies and their targets, providing insights into ...

Explore how direct cell lysis can reduce sample preparation steps and support efficient gene expression analysis by RT-qPCR.

BCG vaccination reduced tau pathology and neuroinflammation in mice, prompting researchers to investigate whether trained immunity could inform future treatments for Alzheimer’s disease.

Advances in biolayer interferometry enable the analysis of small molecule interactions, providing new insights into binding kinetics and affinity.

On the one hand, lab technology has seen tremendous advancements in the past 50 years. The instruments are more sophisticated than ever and are powered by informatics solutions that enable scientists ...

Trish Meek is Senior Director and Portfolio Owner, Connected Science, at Waters Corporation, where she leads product strategy for the company’s laboratory informatics portfolio. She has worked in ...